Sign in to my dashboard Create an account

Cloud for Pharma: The path to digital transformation

scientist working

Share this page

Linda Kallfa

Digital transformation is all about becoming a digital enterprise: an organization that uses technology to continually evolve all aspects of its business. As technology evolves, so does the business. For pharmaceutical companies, digital transformation means experimenting with new technology and rethinking current approaches—from discovery and clinical trials to manufacturing, marketing, and post-marketing surveillance.

Digital transformation also means automation of processes to run the business efficiently, increase productivity, and stimulate innovation while improving the patient experience.

Some digital transformation use cases in pharma are advanced analytics; accuracy and quality; cost savings; security; and efficiency and productivity.

Cloud is at the forefront of the technologies leading digital transformation in the pharmaceutical industry. Cloud infrastructure is bringing in a new era of innovation and automation of business transformation alongside efficiency, cost savings, and security.

Why cloud-led digital transformation is beneficial for pharma

The scalability and agility of the cloud can help pharma companies of all sizes streamline clinical research, enhance innovation, and reduce costs, while simultaneously making it possible to grow effortlessly as business needs expand.

According to industry experts, cloud computing is the infrastructure that pharma organizations need to enable true digital transformation. In a vast number of use cases—from discovery to development and clinical research—different types and sources of data need to access each other in real time. In discovery and clinical trials, pharma organizations are generating huge amounts of data that have to be summarized and archived.

Pharma companies must access customer data for healthcare providers in order to look at affiliation or prescribing history. Most of the time that data resides in other databases. But with cloud computing, pharmaceutical professionals can access and leverage data in the cloud, and they can use other cloud tools like AI and data analytics to derive next steps.

Another benefit is the power to scale up quickly. The beauty of a cloud-based system is that it’s completely painless to scale up when you need more data. You can also scale back down when you need less—for example, when a big project is over.

The traditional drug lifecycle of 10 or more years isn’t feasible anymore. Researchers are constantly seeking ways to conduct mission-critical research and development work in significantly shorter spans of time. Cloud computing enables the pharma community to innovate rapidly, manage changes effortlessly, and deliver new medicines to market faster.

Cloud-based infrastructure offers secure storage for sizable and sensitive information. It also supports data security, integrity, and compliance with regulatory entities. Cloud environments are also secure when it comes to control over and access to data. Reputable cloud service providers offer continuous security monitoring and incident response, and they can quickly identify security issues and apply patches.

Learn more

The right partner is critical for your cloud journey. Only NetApp® provides the leading innovations and technical know-how you need to power patient-centric, data-driven insights across pharma, healthcare, and life sciences. Accelerate clinical insights and improve health outcomes with industry-leading, validated, and certified solutions.

Learn more about what NetApp can do for you.

Linda Kallfa

Linda leads the Life Sciences practice within the Healthcare and Life Sciences team. She brings her wealth of Pharmaceuticals and Life Sciences experience to conversations with customers, connecting the value of NetApp product and services to the line of business with focus on drug discovery, virtual and hybrid clinical trials, image analytics, digital, and beyond the pill initiatives. With 15 years of global experience, Linda started her career at GlaxoSmithKline R&D working as an innovation scientist at their Centre of Excellence. She then managed the clinical development of various brands while working in partnership with global commercial teams. 

Wanting to be part of the digital transformation in the pharmaceutical industry, Linda joined Medidata, a pioneering clinical research and data management company where she helped customers across EMEA adopt the Medidata Rave platform. Linda then joined QAD, an end-to-end ERP provider, as a business development executive in their Life Sciences business unit. She advised pharma and medical devices clients on ERP solutions for their quality, supply chain, and digital manufacturing departments. In partnership with solution marketing Linda started an early ERP adoption program for Cell and Gene manufacturers. Linda is a member of Healthcare Businesswomen`s Association (HBA).

View all Posts by Linda Kallfa

Next Steps

Drift chat loading